logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 3
  • 1
    Toumazou, Christofer
    Born in July 1961
    Individual (22 offsprings)
    Officer
    2015-09-02 ~ now
    OF - Director → CIF 0
  • 2
    Tan, Kong Han
    Born in May 1965
    Individual (7 offsprings)
    Officer
    2015-09-02 ~ now
    OF - Director → CIF 0
  • 3
    DNAE GROUP HOLDINGS LIMITED
    - now 04821572
    DNA ELECTRONICS LIMITED - 2015-09-02
    SUNISEQ LIMITED - 2003-08-22
    56, Wood Lane, London, England
    Active Corporate (19 parents, 4 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Has significant influence or controlCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

DNAE ONCOLOGY LIMITED

Period: 2015-09-02 ~ now
Company number: 09758933
Registered name
DNAE ONCOLOGY LIMITED - now
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Turnover/Revenue
0 GBP2024-01-01 ~ 2024-12-31
0 GBP2023-01-01 ~ 2023-12-31
Cost of Sales
0 GBP2024-01-01 ~ 2024-12-31
0 GBP2023-01-01 ~ 2023-12-31
Gross Profit/Loss
0 GBP2024-01-01 ~ 2024-12-31
0 GBP2023-01-01 ~ 2023-12-31
Distribution Costs
0 GBP2024-01-01 ~ 2024-12-31
0 GBP2023-01-01 ~ 2023-12-31
Administrative Expenses
0 GBP2024-01-01 ~ 2024-12-31
0 GBP2023-01-01 ~ 2023-12-31
Other operating income
0 GBP2024-01-01 ~ 2024-12-31
0 GBP2023-01-01 ~ 2023-12-31
Operating Profit/Loss
0 GBP2024-01-01 ~ 2024-12-31
0 GBP2023-01-01 ~ 2023-12-31
Other Interest Receivable/Similar Income (Finance Income)
0 GBP2024-01-01 ~ 2024-12-31
0 GBP2023-01-01 ~ 2023-12-31
Interest Payable/Similar Charges (Finance Costs)
-215,118 GBP2024-01-01 ~ 2024-12-31
-215,118 GBP2023-01-01 ~ 2023-12-31
Profit/Loss on Ordinary Activities Before Tax
-215,118 GBP2024-01-01 ~ 2024-12-31
-215,118 GBP2023-01-01 ~ 2023-12-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
0 GBP2024-01-01 ~ 2024-12-31
0 GBP2023-01-01 ~ 2023-12-31
Called-up share capital not yet paid and not classified as a current asset
0 GBP2024-12-31
0 GBP2023-12-31
Intangible Assets
0 GBP2024-12-31
0 GBP2023-12-31
Property, Plant & Equipment
0 GBP2024-12-31
0 GBP2023-12-31
Fixed Assets - Investments
0 GBP2024-12-31
0 GBP2023-12-31
Fixed Assets
0 GBP2024-12-31
0 GBP2023-12-31
Total Inventories
0 GBP2024-12-31
0 GBP2023-12-31
Debtors
0 GBP2024-12-31
0 GBP2023-12-31
Cash at bank and in hand
0 GBP2024-12-31
0 GBP2023-12-31
Current assets - Investments
0 GBP2024-12-31
0 GBP2023-12-31
Current Assets
0 GBP2024-12-31
0 GBP2023-12-31
Net Current Assets/Liabilities
-5,853,179 GBP2024-12-31
-5,638,061 GBP2023-12-31
Total Assets Less Current Liabilities
-5,853,179 GBP2024-12-31
-5,638,061 GBP2023-12-31
Creditors
Amounts falling due after one year
0 GBP2024-12-31
0 GBP2023-12-31
Net Assets/Liabilities
-5,853,179 GBP2024-12-31
-5,638,061 GBP2023-12-31
Equity
Called up share capital
100 GBP2024-12-31
100 GBP2023-12-31
Share premium
0 GBP2024-12-31
0 GBP2023-12-31
Retained earnings (accumulated losses)
-5,853,279 GBP2024-12-31
-5,638,161 GBP2023-12-31
Equity
-5,853,179 GBP2024-12-31
-5,638,061 GBP2023-12-31
Average Number of Employees
02024-01-01 ~ 2024-12-31
02023-01-01 ~ 2023-12-31
Bank Borrowings/Overdrafts
Amounts falling due within one year
0 GBP2024-12-31
0 GBP2023-12-31
Finance Lease Liabilities - Total Present Value
Amounts falling due within one year
0 GBP2024-12-31
0 GBP2023-12-31
Trade Creditors/Trade Payables
Amounts falling due within one year
0 GBP2024-12-31
0 GBP2023-12-31
Taxation/Social Security Payable
Amounts falling due within one year
0 GBP2024-12-31
0 GBP2023-12-31
Accrued Liabilities/Deferred Income
Amounts falling due within one year
0 GBP2024-12-31
0 GBP2023-12-31
Other Creditors
Amounts falling due within one year
5,853,179 GBP2024-12-31
5,638,061 GBP2023-12-31

  • DNAE ONCOLOGY LIMITED
    Info
    Registered number 09758933
    Scale Space, 58 Wood Lane, London W12 7RZ
    PRIVATE LIMITED COMPANY incorporated on 2015-09-02 (10 years 9 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-09-01
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.